TGFB1 and pancreatic neoplasm: The activation of PKCα by hypoxia and TGF-β leads to aggressive pancreatic cancer [110] (see Figure 4), and TGF-β also plays a role in PKCα-induced drug resistance in pancreatic cancer [150].